Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of… Grant US-11458119-B2 United States of America 04 Oct 2022
Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of… Grant US-10888547-B2 United States of America 12 Jan 2021
PHARMACEUTICAL COMPOSITION OF THE GLUCOSYLCERAMIDE SYNTHASE INHIBITOR ELIGLUSTAT FOR THE… Application EP-3599237-A1 European Patent Office 29 Jan 2020
ELIGLUSTAT (GENZ 112638) AS INHIBITOR OF GLUCOSYLCERAMIDE SYNTHASE FOR USE IN A METHOD OF… Grant EP-3133070-B1 European Patent Office 14 Aug 2019
METHODS FOR TREATING GAUCHER DISEASE Application WO-2019118707-A1 World Intellectual Property Organisation (WIPO) 20 Jun 2019
Methods for the administration of iloperidone Grant US-10272076-B2 United States of America 30 Apr 2019
OPTIMIZATION AND INDIVIDUALIZATION OF MEDICATION SELECTION AND DOSING Application EP-3223182-A1 European Patent Office 27 Sep 2017
Methods for the administration of iloperidone Grant US-9138432-B2 United States of America 22 Sep 2015
Genz 112638 for treating Gaucher or Fabry disease in combination therapy Application EP-2796457-A1 European Patent Office 29 Oct 2014
Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype Grant US-8688385-B2 United States of America 01 Apr 2014
Optimization and individualization of medication selection and dosing Grant US-8589175-B2 United States of America 19 Nov 2013
Methods for the administration of iloperidone Grant US-8586610-B2 United States of America 19 Nov 2013
Optimization and individualization of medication selection and dosing Application EP-2508621-A1 European Patent Office 10 Oct 2012
Methods for the administration of iloperidone Application EP-2479290-A2 European Patent Office 25 Jul 2012